Breaking News

Tweet TWEET

Seahawks’ Sherman, Browner Facing Four-Game Drug Bans, ESPN Says

Photographer: Brian Bahr/Getty Images

Cornerback Brandon Browner of the Seattle Seahawks. Close

Cornerback Brandon Browner of the Seattle Seahawks.

Close
Open
Photographer: Brian Bahr/Getty Images

Cornerback Brandon Browner of the Seattle Seahawks.

Seattle Seahawks starting cornerbacks Richard Sherman and Brandon Browner face four-game suspensions for violating the National Football League’s performance-enhancing drug policy, ESPN reported.

Both players tested positive for undisclosed banned substances and have filed appeals that may be heard as early as this week, ESPN said, citing unidentified people in the league.

The Seahawks released a statement that they “are aware” of the report, ESPN said. An e-mail seeking comment from Dave Pearson, a spokesman for the team, wasn’t immediately returned. Greg Aiello, a spokesman for the NFL, declined to comment on the report in an e-mail.

Sherman, a 24-year-old second-year player out of Stanford University, leads the Seahawks with four interceptions and three forced fumbles. He had three tackles yesterday in a 24-21 loss to the Miami Dolphins.

“This issue will be resolved soon and the truth will come out. Not worried,” Sherman said in a Twitter post last night.

Browner, 28, has three interceptions and two forced fumbles this season for the Seahawks, who at 6-5 trail the San Francisco 49ers (8-2-1) in the National Football Conference West Division. After playing at Oregon State University, Browner had six interceptions, scoring twice, as an NFL rookie in 2011.

Photographer: Christian Petersen/Getty Images

Cornerback Richard Sherman of the Seattle Seahawks. Close

Cornerback Richard Sherman of the Seattle Seahawks.

Close
Open
Photographer: Christian Petersen/Getty Images

Cornerback Richard Sherman of the Seattle Seahawks.

To contact the reporter on this story: Mason Levinson in New York at mlevinson@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.